| 产品名称: | Staphylococcus aureus subsp. aureus Rosenbach |
|---|---|
| 商品货号: | TS214564 |
| Deposited As: | Staphylococcus aureus Rosenbach |
| Strain Designations: | Serotype 336 |
| Application: | Used to produce vaccine Enteric Research |
| Isolation: | Urine |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties: | Serotype 336 (Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998) |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions: | Temperature: 37.0°C Atmosphere: Aerobic |
| Name of Depositor: | NABI |
| U.S. Patent Number: | |
| References: | Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998 NABI, personal communication Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998 Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998 |